Daan Gene Co., Ltd.

Shenzhen Stock Exchange 002030.SZ

Daan Gene Co., Ltd. Revenue for the year ending December 31, 2023: USD 166.33 M

Daan Gene Co., Ltd. Revenue is USD 166.33 M for the year ending December 31, 2023, a -90.47% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Daan Gene Co., Ltd. Revenue for the year ending December 31, 2022 was USD 1.75 B, a 44.72% change year over year.
  • Daan Gene Co., Ltd. Revenue for the year ending December 31, 2021 was USD 1.21 B, a 47.41% change year over year.
  • Daan Gene Co., Ltd. Revenue for the year ending December 31, 2020 was USD 818.27 M, a 418.87% change year over year.
  • Daan Gene Co., Ltd. Revenue for the year ending December 31, 2019 was USD 157.70 M, a -26.65% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Shenzhen Stock Exchange: 002030.SZ

Daan Gene Co., Ltd.

CEO Ms. Luo Huang
IPO Date Aug. 9, 2004
Location China
Headquarters No.19, Xiangshan Road
Employees 1,968
Sector Health Care
Industries
Description

Daan Gene Co., Ltd. researches and develops, manufactures, and sells clinical test reagents and instruments. The company offers fluorescence quantitative PCR products, time resolution series products, enzyme-linked immunoassay products, instrument products, and scientific research service products. It also provides medical examination, and health consultation and management services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. The company was founded in 2001 and is headquartered in Guangzhou, the People's Republic of China.

Similar companies

002001.SZ

Zhejiang NHU Company Ltd.

USD 2.97

0.01%

002022.SZ

Shanghai Kehua Bio-Engineering Co.,Ltd

USD 0.79

2.66%

000999.SZ

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

USD 5.92

1.98%

002007.SZ

Hualan Biological Engineering Inc.

USD 2.17

2.25%

002049.SZ

Unigroup Guoxin Microelectronics Co., Ltd.

USD 8.16

3.32%

StockViz Staff

January 15, 2025

Any question? Send us an email